SIMPLAAFY Patient Selection
Who is a SIMPLAAFY Patient?
Qualified trial patients must meet all the following criteria.
✓ Patient has documented atrial fibrillation (i.e., atrial fibrillation in the absence of moderate or greater mitral stenosis or a mechanical heart valve) who can tolerate OAC.
✓ Patient has a CHA2DS2‑VASc score of ≥2 for men and ≥3 for women.
✓ Patient is suitable for the protocol defined pharmacologic regimens.
✓ Patient or legal representative is able to understand and willing to provide written informed consent to participate in the trial.
✓ Patient is able and willing to return for required follow-up visits and examinations.
Engage All Patients
SIMPLAAFY seeks to demonstrate LAAC for stroke and bleeding risk reduction in a more inclusive population of NVAF patients, representative of females and people of color.
View results from Boston Scientific's audience research study.
Resources for Trial Candidates
Find a Trial Site
Boston Scientific has selected US sites to be SIMPLAAFY investigational centers. If you have a candidate in mind, view the active trial list provided by clinicaltrials.gov, and reach out to a study physician near you to discuss next steps for referral.